IMP
Process View
regulation of cardiac muscle cell membrane potential
Any process that modulates the establishment or extent of a membrane potential in a cardiac muscle cell (a cardiomyocyte). A membrane potential is the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cardiac muscle cell membrane potential"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.750 | ||
| PTRF | polymerase I and transcript release factor | 0.668 | ||
| ANKFY1 | ankyrin repeat and FYVE domain containing 1 | 0.665 | ||
| ZYX | zyxin | 0.596 | ||
| MICALL1 | MICAL-like 1 | 0.563 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.425 | ||
| STK10 | serine/threonine kinase 10 | 0.309 | ||
| MAP7D1 | MAP7 domain containing 1 | 0.163 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.162 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.140 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.139 | ||
| LMNA | lamin A/C | 0.122 | ||
| FLNA | filamin A, alpha | 0.121 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.118 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.096 | ||
| WDR1 | WD repeat domain 1 | 0.088 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.056 | ||
| EHD4 | EH-domain containing 4 | 0.055 | Human | |
| CANX | calnexin | 0.050 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.040 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.040 | ||
| ACTN1 | actinin, alpha 1 | 0.034 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.033 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.033 | ||
| TUBB6 | tubulin, beta 6 | 0.032 | ||
| CNN2 | calponin 2 | 0.030 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.029 | ||
| PLEC | plectin | 0.028 | ||
| EHD1 | EH-domain containing 1 | 0.022 | Human | |
| MICAL1 | microtubule associated monoxygenase, calponin and LIM domain containing 1 | 0.021 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.021 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.020 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.019 | ||
| TAGLN2 | transgelin 2 | 0.019 | ||
| MYO1C | myosin IC | 0.019 | ||
| AXL | AXL receptor tyrosine kinase | 0.019 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.017 | ||
| ACTN4 | actinin, alpha 4 | 0.017 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.017 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.016 | ||
| UPP1 | uridine phosphorylase 1 | 0.016 | ||
| MGAT1 | mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase | 0.016 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.016 | ||
| CDC42EP2 | CDC42 effector protein (Rho GTPase binding) 2 | 0.015 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.015 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.014 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.013 | ||
| CD97 | CD97 molecule | 0.013 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.012 | ||
| IGFBP6 | insulin-like growth factor binding protein 6 | 0.012 | ||
| FOSL1 | FOS-like antigen 1 | 0.012 | ||
| FAM65A | family with sequence similarity 65, member A | 0.011 | ||
| LOXL1 | lysyl oxidase-like 1 | 0.010 | ||
| SH3GL1 | SH3-domain GRB2-like 1 | 0.010 |